Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10981903 Inhibitors of c-Jun-N-terminal kinase (JNK)

Patent 10981903 was granted and assigned to Dana-Farber Cancer Institute on April, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109819030

Patent Inventor Names

Tinghu Zhang0

Nathanael S. Gray0

Date of Patent

April 20, 2021

Patent Application Number

162029610

Date Filed

November 28, 2018

Patent Citations

‌

US Patent 10000483 Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof

‌

US Patent 10017477 Janus kinase inhibitors and uses thereof

‌

US Patent 10047070 Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

‌

US Patent 10112927 Inhibitors of cyclin-dependent kinase 7 (CDK7)

‌

US Patent 10144730 Inhibitors of c-Jun-

‌

US Patent 10550121 Inhibitors of cyclin-dependent kinases

Patent Citations Received

‌

US Patent 11325910 Inhibitors of cyclin-dependent kinases

Patent Primary Examiner

‌

Tracy Vivlemore

Patent abstract

The present invention provides novel compounds according to Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10981903 Inhibitors of c-Jun-N-terminal kinase (JNK)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API